Stroke is a leading cause of death worldwide and the first cause of disability in the Western world. Over the last 20 years, antiplatelet agents have reduced overall stroke rates in primary and secondary prevention in men. However, this has not been the case for women. In this narrative review, the most widely used antiplatelet therapies for primary and secondary prevention in stroke, excluding cardioembolic stroke, will be outlined. First, the largest randomised controlled trials will be ana...Expand abstract
- Publisher copy:
- Copyright date:
Antiplatelet treatment in primary and secondary stroke prevention in women.
If you are the owner of this record, you can report an update to it here: Report update to this record